Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UPDATE 1-China's Sinochem bids $2.5bln for Australia's Nufarm

Published 09/27/2009, 07:54 PM
Updated 09/27/2009, 07:57 PM

* Sinochem bids $2.5 bln for Nufarm

* Deal subject to Australian foreign investment approval

* Sinochem offering 17 pct premium (Adds details)

SYDNEY, Sept 28 (Reuters) - Chinese state-owned firm Sinochem has agreed in principle to buy Australian farm chemicals group Nufarm Ltd for A$2.8 billion ($2.5 billion), in a deal that will again test investment ties between the two nations.

Nufarm said on Monday it had signed a heads of agreement with Sinochem whereby the Chinese firm would offer A$13.00 per Nufarm share, a near 17 percent premium to Nufarm's last traded price.

The deal is subject to due diligence and regulatory approvals, including consent from Australia's Foreign Investment Review Board which has stymied at least two major Chinese investments in Australia this year on national interest grounds.

The main attraction for Sinochem is Nufarm's global distribution network, which includes businesses in Asia, South America and Europe, analysts have said.

"The execution... is subject to Sinochem being satisfied with the results of its due diligence enquiries and approval by Sinochem and the Nufarm board," the Nufarm statement added.

Nufarm said there was still no certainty a deal would proceed, despite its support for the heads of agreement.

It is the second time Nufarm has received an approach from a Chinese firm in two years. In 2007, China National Chemical Corp, China's leading chemical producer, led a A$3 billion approach with U.S. private equity firms Blackstone Group and Fox Paine Management, but they did not make a formal offer.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nufarm is being advised by UBS, while the Royal Bank of Scotland is advising Sinochem. (Reporting by Denny Thomas; Editing by Mark Bendeich)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.